Skip to main content
Clinical Trials/NCT03958552
NCT03958552CompletedNot Applicable

Palliative Care Consultations for Persons in the Medicare Skilled Nursing Facility (SNF) Setting

University of Maryland, Baltimore1 site in 1 country45 target enrollmentStarted: October 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
45
Locations
1
Primary Endpoint
Number of Participants Who Completed Patient Quality of Life Surveys

Study Overview

Brief Summary

Close to one-third of Medicare decedents use the Medicare skilled nursing facility (SNF) benefit in the 6 months prior to death. SNF care often increases the risk for more aggressive, potentially burdensome treatments and unrecognized or undertreated symptoms. Palliative care is goal-directed, patient and family-centered care that focuses on a wide range of physical, psychosocial, and spiritual needs for persons with serious, life-limiting illnesses. Effective palliative care relieves suffering, enhances communication, and improves end-of-life care and decision making for seriously ill older adults. Despite its association with improved quality of care, higher satisfaction, and better symptom management at the end of life, palliative care is not widely available to Medicare patients in the Skilled Nursing Facility (SNF) setting. Palliative care consultation (PCC) is one approach that can potentially improve care for older adults with advanced illness in SNFs. This pilot study will test an evidence-based palliative care consult intervention for older adult SNF patients in nursing homes by comparing the patient/family caregiver reported quality of life in two participant groups: one receiving a PCC and the other receiving standard care.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Admitted to a participating nursing home under the Medicare SNF benefit
  • •English speaking
  • •If non-verbal or unable to participate in a conversation, a legally authorized representative(LAR) or surrogate decision maker who can participate in the study
  • •A diagnosis of one or more advanced serious illness using established criteria
  • •One global indicator for a PCC at SNF admission (i.e., primary provider would not be surprised if patient died in 12 months; frequent hospital or SNF admissions; complex care requirements; decline in function; feeding intolerance; or unintended decline in weight)

Exclusion Criteria

  • •Patients who have previously received or are referred for a SNF-based PCC by their primary care team

Arms & Interventions

Standard Care

No Intervention

Participants will receive the standard Medicare Skilled Nursing Facility care.

Palliative Care Consult

Experimental

Participants will receive the standard Medicare Skilled Nursing Facility care plus a Palliative Care Consultation with a trained provider.

Intervention: Palliative Care Consultation (Other)

Outcomes

Primary Outcomes

Number of Participants Who Completed Patient Quality of Life Surveys

Time Frame: Collected upon admission to the nursing home and enrollment and again 15-21 days after enrollment in the study (control group) or intervention received (intervention group).

The Patient Outcome Survey (POS) 10 item Survey that measures quality of life in five dimensions: 1) physical; 2) emotional; 3) psychological; 4) spiritual needs, and 5) provision of information and support. Items scored on a 5 point Likert Scale (0=not at all, 4= overwhelmingly) based on symptom/need in the past week. Overall profile score is calculated by summing responses (range 0-40). Higher values represent a worse outcome.

Secondary Outcomes

  • Number of Participants Who Completed the Consult Satisfaction Survey (CSQ)(Collected within 15-21days of palliative care consultation for the intervention group.)
  • Adherence to SNF-PCC Recommendations(30 Days post-admission)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Joan Carpenter

Principal Investigator

University of Maryland, Baltimore

Study Sites (1)

Loading locations...

Similar Trials